➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
McKinsey
Dow
Medtronic
Moodys

Last Updated: February 25, 2021

DrugPatentWatch Database Preview

Carbinoxamine maleate - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for carbinoxamine maleate and what is the scope of patent protection?

Carbinoxamine maleate is the generic ingredient in three branded drugs marketed by Mcneil, Cypress Pharm, Mikart, Vintage Pharms, Aytu, Invagen Pharms, Mission Pharmacal Co, and Ortho Mcneil Pharm, and is included in twelve NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Carbinoxamine maleate has twenty-one patent family members in fourteen countries.

There are seven drug master file entries for carbinoxamine maleate. Six suppliers are listed for this compound.

Drug Prices for carbinoxamine maleate

See drug prices for carbinoxamine maleate

Pharmacology for carbinoxamine maleate

US Patents and Regulatory Information for carbinoxamine maleate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharmacal Co CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090756-001 May 27, 2011 AA RX No No   Start Trial   Start Trial   Start Trial
Invagen Pharms CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 090435-001 Apr 15, 2010 AA RX No No   Start Trial   Start Trial   Start Trial
Vintage Pharms CARBINOXAMINE MALEATE carbinoxamine maleate TABLET;ORAL 040639-002 May 30, 2008 DISCN No No   Start Trial   Start Trial   Start Trial
Ortho Mcneil Pharm CLISTIN carbinoxamine maleate TABLET;ORAL 008915-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Aytu KARBINAL ER carbinoxamine maleate SUSPENSION, EXTENDED RELEASE;ORAL 022556-001 Mar 28, 2013 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Mikart CARBINOXAMINE MALEATE carbinoxamine maleate SOLUTION;ORAL 040458-001 Apr 25, 2003 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Johnson and Johnson
Dow
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.